Doctor's Assessment Included
Every result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
Psilocybin
The Zuiver psilocybin urine screening offers specialised, qualitative detection of psilocybin and psilocin. This targeted test extends beyond standard panels to provide accurate results for comprehensive drug screening programmes.
What It Measures
This test detects the presence of psilocybin and its primary active metabolite psilocin in urine. After ingestion, psilocybin is rapidly converted to psilocin, which is responsible for the psychoactive effects. The test provides a qualitative result indicating whether these metabolites are present above the assay cut-off level.
Why It Matters
Psilocybin use may be associated with altered perception, impaired judgement, and psychological distress in some individuals. Detection can be relevant for clinical assessment, treatment monitoring, and forensic evaluations. Consult a healthcare professional for interpretation of results.
When to Test
Testing may be relevant when psilocybin use is suspected, as part of extended drug screening panels, or during clinical evaluations. Psilocybin is not typically included in standard workplace drug tests, so targeted screening may be required. Consult a healthcare professional for guidance.
Lifestyle Tips
Prioritise your mental health through regular physical activity, adequate sleep, and evidence-based stress management. If you have concerns about substance use, speak with a qualified healthcare professional who can offer appropriate support and guidance.
Frequently Asked Questions
How long can psilocybin be detected in urine?
Psilocybin and its metabolite psilocin are typically detectable in urine for up to 24 to 48 hours after use. The relatively short detection window means timing of the test is an important factor. Consult a healthcare professional for more information.
Is psilocybin included in standard drug screening panels?
Psilocybin is generally not included in standard workplace drug screening panels such as the 5-panel or 10-panel tests. A specific, targeted assay is required to detect psilocybin and psilocin in urine.